Newly diagnosed patients with cancer at increased risk for stroke
the ONA take:
According to a new study published in the journal Annals of Neurology, researchers at Weill Cornell Medical College in New York City, New York, have found that newly diagnosed patients with cancer, particularly those with more aggressive disease, are at an increased risk for stroke in the months following diagnosis.
For the study, researchers analzyed Medicare claims from 2001 to 2009 by patients who had been diagnosed with colorectal, prostate, breast, lung, and pancreatic cancer. Results showed that compared to seniors without cancer, those with cancer had a much risk for stroke, especially during the first 3 months following cancer diagnosis.
Patients with colorectal, lung, and pancreatic cancer had the highest risk of stroke, as those diseases are often more aggressive at the time of diagnosis. Those with breast and prostate cancer had the lowest risk for stroke as those diseases are typically diagnosed as localized tumors.
Although the study was not designed to determine why patients with cancer have an increased risk for stroke, the researchers suggest that cancer and the treatments for cancer affect the circulatory and coagulation systems. The researchers note that patients should be advised of the signs and symptoms of stroke as it can delay cancer treatment and cause disability and death.
Newly diagnosed patients with cancer are at an increased risk for stroke in the months following diagnosis.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|